Chang Yong Yun1, Nayoung Kim1,2,3, Jaebong Lee4, Ju Yup Lee1,5, Young Jae Hwang1, Hye Seung Lee6, Hyuk Yoon1,3, Cheol Min Shin1,3, Young Soo Park1,3, Jin-Wook Kim1, Dong Ho Lee1,2,3. 1. Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea. 2. Department of Internal Medicine and Liver Research Institute, Seoul National University Seoul, South Korea. 3. Tumor Microenvironment Global Core Research Center, Seoul National University Seoul, South Korea. 4. Division of Statistics in Medical Research Collaborating Center, Seoul National University Bundang Hospital, Seongnam, South Korea. 5. Department of Internal Medicine, Keimyung University School of Medicine, Daegu, South Korea. 6. Departments of Pathology, Seoul National University Bundang Hospital, Seongnam, South Korea.
Abstract
BACKGROUND: The operative link on gastric atrophy (OLGA) and operative link on gastric intestinal metaplasia (OLGIM) stages have been suggested for risk estimation of gastric cancer (GC). However, usefulness of OLGA/OLGIM systems in diffuse type of GC was not investigated so far. The aims of this study were to evaluate the OLGA/OLGIM systems in estimating the GC risk according to Lauren's classification and to investigate the interaction among the risk factors. MATERIALS AND METHODS: The OLGA/OLGIM stages were evaluated in 1398 (765 control and 633 GC patients) who were prospectively enrolled in the Seoul National University Bundang Hospital. Synergistic interaction among the risk factors for GC was calculated using an additive model. RESULTS: Among 387 intestinal-type GC patients, 71 (18.3%) were high-risk OLGA stages (III, IV) and 113 (29.2%) were high-risk OLGIM stages (III, IV). Of the 246 patients with diffuse-type GC, 36 (14.6%) were high-risk OLGA stages and 39 (15.9%) were high-risk OLGIM stages. Multivariable analysis revealed family history of GC, Helicobacter pylori infection, high-risk OLGA stages, and high-risk OLGIM stages as independent risk factors for GC regardless of histologic type (odds ratios [ORs] 1.78, 1.94, 2.63, and 3.18, respectively). There was no significant risk modification among the H. pylori infection, family history of GC, and high-risk OLGA/OLGIM stages. CONCLUSION: High-risk OLGA/OLGIM stages are important prediction markers for GC regardless of H. pylori infection or family history of GC not only for the intestinal type but also for diffuse-type GC.
BACKGROUND: The operative link on gastric atrophy (OLGA) and operative link on gastric intestinal metaplasia (OLGIM) stages have been suggested for risk estimation of gastric cancer (GC). However, usefulness of OLGA/OLGIM systems in diffuse type of GC was not investigated so far. The aims of this study were to evaluate the OLGA/OLGIM systems in estimating the GC risk according to Lauren's classification and to investigate the interaction among the risk factors. MATERIALS AND METHODS: The OLGA/OLGIM stages were evaluated in 1398 (765 control and 633 GC patients) who were prospectively enrolled in the Seoul National University Bundang Hospital. Synergistic interaction among the risk factors for GC was calculated using an additive model. RESULTS: Among 387 intestinal-type GC patients, 71 (18.3%) were high-risk OLGA stages (III, IV) and 113 (29.2%) were high-risk OLGIM stages (III, IV). Of the 246 patients with diffuse-type GC, 36 (14.6%) were high-risk OLGA stages and 39 (15.9%) were high-risk OLGIM stages. Multivariable analysis revealed family history of GC, Helicobacter pylori infection, high-risk OLGA stages, and high-risk OLGIM stages as independent risk factors for GC regardless of histologic type (odds ratios [ORs] 1.78, 1.94, 2.63, and 3.18, respectively). There was no significant risk modification among the H. pyloriinfection, family history of GC, and high-risk OLGA/OLGIM stages. CONCLUSION: High-risk OLGA/OLGIM stages are important prediction markers for GC regardless of H. pyloriinfection or family history of GC not only for the intestinal type but also for diffuse-type GC.
Authors: John E Wang; Sung Eun Kim; Bong Eun Lee; Sungho Park; Joo Ha Hwang; Robert J Huang Journal: Cancer Causes Control Date: 2021-11-19 Impact factor: 2.506
Authors: Ki Wook Kim; Nayoung Kim; Yonghoon Choi; Won Seok Kim; Hyuk Yoon; Cheol Min Shin; Young Soo Park; Dong Ho Lee; Young Suk Park; Sang-Hoon Ahn; Do Joong Park; Hyung-Ho Kim; Hye Seung Lee; Ji-Won Kim; Jin Won Kim; Keun-Wook Lee; Won Chang; Ji Hoon Park; Yoon Jin Lee; Kyoung Ho Lee; Young Hoon Kim Journal: Gastric Cancer Date: 2021-02-18 Impact factor: 7.370
Authors: Jonathan W J Lee; Feng Zhu; Supriya Srivastava; Stephen Kk Tsao; Christopher Khor; Khek Yu Ho; Kwong Ming Fock; Wee Chian Lim; Tiing Leong Ang; Wan Cheng Chow; Jimmy Bok Yan So; Calvin J Koh; Shijia Joy Chua; Andrew S Y Wong; Jaideepraj Rao; Lee Guan Lim; Khoon Lin Ling; Chung-King Chia; Choon Jin Ooi; Andrea Rajnakova; Wai Ming Yap; Manuel Salto-Tellez; Bow Ho; Richie Soong; Kee Seng Chia; Yik Ying Teo; Ming Teh; Khay-Guan Yeoh Journal: Gut Date: 2021-05-11 Impact factor: 23.059